Showing results (1271-1280 of 4,218) with videos related to
Sort By:
Pageof 422
Discover Oncology|August 21, 2023
A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.govJing Yang, Heming Kang, Liyang Lyu, et al.Discover Oncology|August 19, 2023
Classification and function of γδT cells and its research progress in anti-glioblastomaYujuan Zhao, Renhong Zhu, Yashu Wang, et al.Discover Oncology|October 19, 2023
Regulation of T cells by myeloid-derived suppressor cells: emerging immunosuppressor in lung cancerZhong-Ning He, Chun-Yu Zhang, Yu-Wei Zhao, et al.Discover Oncology|October 20, 2023
PIK3CD correlates with prognosis, epithelial-mesenchymal transition and tumor immune infiltration in breast carcinomaWenxing He, Haoyi Zhang, Hong Cheng, et al.Discover Oncology|October 25, 2023
Necroptosis-related genes are associated with prognostic features of kidney renal clear cell carcinomaYiduo Wang, Ke-Hao Pan, Ming ChenDiscover Oncology|October 24, 2023
Evaluation of the relationship between Ki67 expression level and neoadjuvant treatment response and prognosis in breast cancer based on the Neo-Bioscore staging systemYurdanur Sullu, Leman Tomak, Guzin Demirag, et al.Discover Oncology|October 24, 2023
ZDHHC9: a promising therapeutic target for triple-negative breast cancer through immune modulation and immune checkpoint blockade resistanceChao Xu, Yongjie Xie, Peng Xie, et al.Discover Oncology|September 23, 2023
Synergist for antitumor therapy: Astragalus polysaccharides acting on immune microenvironmentQian Xu, Wen Cheng, Jinrui Wei, et al.Discover Oncology|July 3, 2023
Perirenal fat stranding as a predictor of disease progression after radical nephroureterectomy for renal pelvic urothelial carcinoma: a retrospective studyMasato Yanagi, Mika Terasaki, Tomonari Kiriyama, et al.Discover Oncology|June 30, 2023
TRAF inhibition drives cancer cell apoptosis and improves retinoic acid sensitivity in multiple cancers modelsKun Zhong, Xiaojun Liu, Weihua Ding, et al.Pageof 422